# Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI

Study · id `cardio:ct-nct02325973` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02325973](<https://clinicaltrials.gov/study/NCT02325973>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02325973

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 242 participants.

## Technical summary

Registry record NCT02325973. Allocation not applicable; no masking; primary purpose diagnostic. Start 2013-06 (registry gives no type); primary completion 2018-02 (actual). Results posted on 2025-08-08.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 242 participants (enrolled count; ClinicalTrials.gov record NCT02325973, source copy `cardio:ctgov-nct02325973-2025-08-08`, retrieved 2026-10-26)
- Start date: 2013-06 (registry gives no type) (ClinicalTrials.gov record NCT02325973, source copy `cardio:ctgov-nct02325973-2025-08-08`, retrieved 2026-10-26)
- Primary completion: 2018-02 (actual) (ClinicalTrials.gov record NCT02325973, source copy `cardio:ctgov-nct02325973-2025-08-08`, retrieved 2026-10-26)
- Completion: 2018-02 (actual) (ClinicalTrials.gov record NCT02325973, source copy `cardio:ctgov-nct02325973-2025-08-08`, retrieved 2026-10-26)
- Results first posted: 2025-08-08 (ClinicalTrials.gov record NCT02325973, source copy `cardio:ctgov-nct02325973-2025-08-08`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT02325973, source copy `cardio:ctgov-nct02325973-2025-08-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02325973-2025-08-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI
- Acronym: AMICRO
- Condition: Multi Vessel Coronary Artery Disease
- Condition: STEMI
- Intervention (Device): PressureWire Certus guidewire
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: d906325cc8fd2ffe112d5fea0c8dd68c17e648d89293d02bd0c459939bd38676
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
